EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Novel PROTAC probes targeting KDM3 degradation to eliminate colorectal cancer stem cells through inhibition of Wnt/β-catenin signaling

Shadid U Zaman, Piyusha P Pagare, Hongguang Ma, Rosalie G Hoyle, Yan Zhang iD, Jiong Li iD

RSC Medicinal Chemistry · 2024 · 15 (11) · 3746-3758

DOI: 10.1039/d4md00122b ↗

Kurz gefasst

Fachartikel in der Zeitschrift RSC Medicinal Chemistry, 2024. Verfasst von Shadid U Zaman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University Richmond Virginia 23298-0540 USA yzhang2@vcu.edu jli29@vcu.ed…. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: NIDCR NIH HHS, NCATS NIH HHS, Virginia Commonwealth University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We designed and synthesized novel IOX1-based PROTACs, which can selectively degrade KDM3A and KDM3B to eliminate colorectal cancer stem cells through inhibition of Wnt signaling.

Autor:innen und Institutionen

  • Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University Richmond Virginia 23298-0540 USA yzhang2@vcu.edu jli29@vcu.edu.
  • Department of Oral and Craniofacial Molecular Biology, Virginia Commonwealth University Richmond Virginia 23298-0540 USA.
  • Massey Cancer Center, Virginia Commonwealth University Richmond Virginia 23298-0540 USA.

ORCID-Profile: Yan Zhang, Jiong Li

Förderung

  • NIDCR NIH HHS
  • NCATS NIH HHS
  • Virginia Commonwealth University
  • Common Fund

Zitieren

APA

Zaman, S. U., Pagare, P. P., Ma, H., Hoyle, R. G., Zhang, Y., & Li, J. (2024). Novel PROTAC probes targeting KDM3 degradation to eliminate colorectal cancer stem cells through inhibition of Wnt/β-catenin signaling. RSC Medicinal Chemistry, 15(11), 3746-3758. https://doi.org/10.1039/d4md00122b

Vancouver

Zaman SU, Pagare PP, Ma H, Hoyle RG, Zhang Y, Li J. Novel PROTAC probes targeting KDM3 degradation to eliminate colorectal cancer stem cells through inhibition of Wnt/β-catenin signaling. RSC Medicinal Chemistry. 2024;15(11):3746-3758. doi:10.1039/d4md00122b

BibTeX
@article{Zaman2024,
  author = {Zaman, Shadid U and Pagare, Piyusha P and Ma, Hongguang and Hoyle, Rosalie G and Zhang, Yan and Li, Jiong},
  title = {Novel PROTAC probes targeting KDM3 degradation to eliminate colorectal cancer stem cells through inhibition of Wnt/β-catenin signaling},
  journal = {RSC Medicinal Chemistry},
  year = {2024},
  volume = {15},
  number = {11},
  pages = {3746--3758},
  doi = {10.1039/d4md00122b}
}
Kostenlos starten →